Together with our friends from Harvard, MassBio and the Life Science community we recently attended the Digital Health Impact 2019 in Boston. The importance, challenges and opportunities within Digital Health were discussed. This emerging sector and platforms such as Stardots’ AI-TRUST, reflect combined advances in the Life Sciences, Digital Technology and Medical Devices industries. All bringing to light the question….How do we apply all this data to really impact outcomes and reduce costs?
We discussed digital health and Software-as-a-Drug in general and Stardots´ platform for Parkinson’s Disease “AI-TRUST” with the attendees including the Governor of Massachusetts Charlie Baker, CBO of MassBio John Hallinan, Harvard lecturer Luba Greenwood and co-founder of Flare Capital Bill Geary. We really learned a lot from the event. The future for digital health platforms such as ours is bright.
A reoccurring issue was the realization and real-world benefits of digital health platforms. We believe that such a platform should be developed in strong collaboration with the life science and health care sector. AI-TRUST is a joint venture between Stardots, Uppsala University and Uppsala University Hospital and we are working closely with neurological clinics and professionals in EU and the U.S.